Business Context and Reporting Period
Company: The Ensign Group, Inc. (ENSG)
Filing Type: Form 8-K (Current Report)
Date of Report: July 25, 2024
Reporting Period: Second Quarter ended June 30, 2024
Business Overview: The Company operates in healthcare services and real estate segments. This filing serves to announce the issuance of a press release detailing financial results for the quarter.
Key Financial Metrics
The provided text is a cover document referencing a press release (Exhibit 99.1) and does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing defines the following non-GAAP financial measures used in the referenced press release:
- EBITDA: Net income before interest, taxes, depreciation, and amortization.
- Adjusted EBITDA: EBITDA further adjusted for stock-based compensation, acquisition costs, system implementation costs, litigation, asset impairments, and business interruption recoveries.
- Adjusted EBITDAR: Adjusted EBITDA further adjusted for rent-cost of services (noted as a valuation measure, not a performance measure).
- Adjusted EBT: Net income before taxes, stock-based compensation, acquisition costs, system implementation costs, litigation, impairments, business interruption recoveries, and depreciation of patient base intangibles.
- Funds from Operations (FFO): Applicable to the Standard Bearer real estate segment; segment income excluding real estate depreciation/amortization, gains/losses on real estate sales, insurance recoveries, and impairments.
Material Changes
The filing text does not provide specific data regarding material changes in financial performance compared to the prior comparable period. It only confirms that results for the second quarter ended June 30, 2024, have been reported via a separate press release.
Guidance, Outlook, and Risks
Management Commentary: Management states that the presentation of non-GAAP measures provides supplemental information to evaluate operating performance, noting that excluded items are often infrequent, variable, or non-cash in nature.
Risks and Limitations: The filing explicitly warns that non-GAAP measures may not be comparable to those of other companies in the industry and should not be relied upon to the exclusion of GAAP measures (Net Income and Diluted EPS).
Guidance: No specific forward-looking guidance or outlook figures are included in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated July 25, 2024) for actual revenue, net income, and EPS figures.
- Verify the reconciliation tables between GAAP Net Income and the defined non-GAAP measures (Adjusted EBITDA, FFO, etc.).
- Check the Form 10-Q for the quarter ended June 30, 2024, for detailed segment performance and liquidity data.
- Confirm the specific impact of "business interruption recoveries" and "litigation" costs mentioned in the non-GAAP adjustments.